Health Care

Pfizer on buying spree with AstraZeneca antibiotics deal

Drugmaker Pfizer Inc. is continuing its shopping spree with its fourth acquisition since the April collapse of its planned $160 billion megadeal to buy rival Allergan PLC and move its headquarters, on paper, to Allergan's base in lower-tax Ireland.

China sets sights on new global export: nuclear energy

On a seaside field south of Shanghai, workers are constructing a nuclear reactor that is the flagship for Beijing's ambition to compete with the United States, France and Russia as an exporter of atomic power technology.

How EpiPen's maker raised prices, and hackles, so much

Sky-high price hikes for EpiPen, the injected emergency medicine for severe allergic reactions to foods and bug bites, have made its maker the latest target for patients and politicians infuriated by soaring drug prices.